The Supreme Court's decision to uphold Affordable Care Act insurance subsidies in all 50 states was greeted warmly by major healthcare associations and by Wall Street. However, the decision in King vs. Burwell also served to reignite debate over the healthcare law, and the challenges that remain 5 years after its passage.
Effective clinical research into the causes and treatments associated with large vessel vasculitis can be a challenge. The rarity of the disease limits the potential for randomized, controlled trials and the paucity of generally accepted outcome measures makes it difficult to assess treatments. A study in The Journal of Rheumatology outlined a concerted effort to tackle both of these challenges.
The US Supreme Court has said residents of all 50 states are entitled to subsidies, regardless of whether they bought insurance through a federally run or state-run marketplace. The case centered on whether 2010's Affordable Care Act authorized subsidies to consumers who bought health insurance on non-state-run insurance marketplaces.
It should be common knowledge that prescription opioids have addictive properties, yet alarming survey results reveal that many healthcare providers do not understand the extent to which this is the case.